-
Portal Biotech Secures $35 Million to Advance AI-Powered, Full-Length Protein Sequencing
Portal Biotech has raised $35 million in a Series A funding round, primarily to develop its innovative single-molecule protein sequencing platform. Co-led by the NATO Innovation Fund, this investment aims to advance proteomics and make protein analysis more accessible for labs, potentially transforming drug discovery and precision medicine.
